RE:RE:RE:RE:RE:RE:and meanwhile back in china hepa is still not trading...gv, RVX had eliminated lipitor-208 from the initial P3 (pivotal) trial i presume they had did all the legwork to elminate lipitor-208 (relisten to some of the statements made and how sure they were and what they learned and blah, blah, blah)...they know lipitor-208 failed in ASSURE and had all data related to that to decide whether to include in a P3 and decided against it and now flip-flopped and are now including...IMO this is a PII (like ASSURE) but RVX is hoping with enough patients to pass the data tests for registration..ps re mono i thought 208 had positive clinical impact on its own but a combo with statins would prove synergistic (effect timeline would be shortened as wasn't that their claim in one of the failed trials it just took 208 too long (maybe needed 26 weeks)...ps on a different note i made a post on BTI MB and it speaks to a real problem on these MB, pikupstix made a fundamentally WABS claim (and as he is a professional i felt compelled to correct and shame him) good news for BTI but not "earth shattering" as he was trying to pump...ps public flip-flops imo are incompetence i want to hear specifically why lipitor-208 now included..same as ODD pump job they know how long it takes